株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

光干渉断層診断装置 (OCT) :医療機器のパイプライン評価

Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 357850
出版日 ページ情報 英文 78 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.19円で換算しております。
Back to Top
光干渉断層診断装置 (OCT) :医療機器のパイプライン評価 Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2019
出版日: 2019年12月16日 ページ情報: 英文 78 Pages
概要

当レポートでは、光干渉断層診断装置 (OCT) 関連のパイプライン製品について調査しており、開発段階別の動向や製品の主要開発企業、現在継続中の治験、業界における近年の動向などの情報をお届けします。

第1章 目次

第2章 イントロダクション

  • 光干渉断層診断装置 (OCT)の概要

第3章 開発中の製品

  • 光干渉断層診断装置 (OCT) - パイプライン製品:開発段階別
  • 光干渉断層診断装置 (OCT) - パイプライン製品:地域 (国) 別
  • 光干渉断層診断装置 (OCT) - パイプライン製品:規制経路別
  • 光干渉断層診断装置 (OCT) - パイプライン製品:承認時期別 (推定)
  • 光干渉断層診断装置 (OCT) - 継続中の治験

第4章 光干渉断層診断装置 (OCT) - 開発中のパイプライン製品:企業別

  • 光干渉断層診断装置 (OCT)企業 - パイプライン製品:開発段階別
  • 光干渉断層診断装置 (OCT) - パイプライン製品:開発段階別

第5章 光干渉断層診断装置 (OCT) 開発企業と製品の概要

  • Canon U.S.A., Inc.
  • Cleveland Clinic Hospital
  • Compact Imaging Inc.
  • Duke University
  • George Washington University
  • Heidelberg Engineering GmbH
  • Leica Microsystems GmbH
  • OptoQuest
  • Optos Plc
  • Sinoora Inc.
  • University of California, Berkeley
  • University of Rochester
  • Volcano Corporation

第6章 光干渉断層診断装置 (OCT) - 近年の動向

第7章 付録

図表

List of Tables

  • Table 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
  • Table 2: Optical Coherence Tomography (OCT) - Pipeline Products by Territory
  • Table 3: Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
  • Table 4: Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
  • Table 5: Optical Coherence Tomography (OCT) - Ongoing Clinical Trials
  • Table 6: Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
  • Table 7: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
  • Table 8: Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: SPOCT HR - Product Status
  • Table 10: SPOCT HR - Product Description
  • Table 11: Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: ZEISS CIRRUS 6000 - Product Status
  • Table 13: ZEISS CIRRUS 6000 - Product Description
  • Table 14: Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: MRO Optical Imaging Sensor - Product Status
  • Table 16: MRO Optical Imaging Sensor - Product Description
  • Table 17: Conavi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Novasight Hybrid System - Product Status
  • Table 19: Novasight Hybrid System - Product Description
  • Table 20: Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: MD-SD-OCT Instrument - Product Status
  • Table 22: MD-SD-OCT Instrument - Product Description
  • Table 23: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: HH - SDOCT - Product Status
  • Table 25: HH - SDOCT - Product Description
  • Table 26: Microscope Integrated OCT System - Product Status
  • Table 27: Microscope Integrated OCT System - Product Description
  • Table 28: Whole Eye Optical Coherence Tomography Scanner - Product Status
  • Table 29: Whole Eye Optical Coherence Tomography Scanner - Product Description
  • Table 30: George Washington University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Amplified Bimorph Scanning Mirror System - Product Status
  • Table 32: Amplified Bimorph Scanning Mirror System - Product Description
  • Table 33: Haag-Streit AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: EYESTAR 900 - Product Status
  • Table 35: EYESTAR 900 - Product Description
  • Table 36: Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Cataract And Refractive Imaging Device - Product Status
  • Table 38: Cataract And Refractive Imaging Device - Product Description
  • Table 39: SPECTRALIS OCT2 Module - OCT Angiography - Product Status
  • Table 40: SPECTRALIS OCT2 Module - OCT Angiography - Product Description
  • Table 41: Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: DI-SDOCT Imaging System - Product Status
  • Table 43: DI-SDOCT Imaging System - Product Description
  • Table 44: SDOCT Scanner - Product Status
  • Table 45: SDOCT Scanner - Product Description
  • Table 46: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Binocular Optical Coherence Tomography - Product Status
  • Table 48: Binocular Optical Coherence Tomography - Product Description
  • Table 49: Moorfields Eye Hospital NHS Foundation Trust - Ongoing Clinical Trials Overview
  • Table 50: Binocular Optical Coherence Tomography - The Future of Cataract Assessment: Investigation of the Utility of a Novel Binocular OCT System for Clinical Application
  • Table 51: Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: High - Speed Wavelength Swept Light - Based OCT Device - Product Status
  • Table 53: High - Speed Wavelength Swept Light - Based OCT Device - Product Description
  • Table 54: Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Notal Home OCT System - Product Status
  • Table 56: Notal Home OCT System - Product Description
  • Table 57: Notal Vision Inc - Ongoing Clinical Trials Overview
  • Table 58: Notal Home OCT System - Comparison Between Retinal Images Captured by NOTAL-OCT V2.5 and Zeiss Cirrus / Heidelberg Spectralis SD OCT - Study Protocol
  • Table 59: Notal Home OCT System - Patient-operated Home OCT Device for Monitoring Patients Diagnosed with Exudative Age-related Macular Degeneration (eAMD): First US Clinical Trial
  • Table 60: Notal Home OCT System - Retinal Imaging Using NOTAL-OCT
  • Table 61: Notal Home OCT System - Retinal Imaging Using NOTAL-OCT V2.5
  • Table 62: OptoQuest Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: Vectralis - Product Status
  • Table 64: Vectralis - Product Description
  • Table 65: Optos Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: Falcon I - Product Status
  • Table 67: Falcon I - Product Description
  • Table 68: Falcon II - Product Status
  • Table 69: Falcon II - Product Description
  • Table 70: Lotte - Product Status
  • Table 71: Lotte - Product Description
  • Table 72: Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Intelligent OCT Retinal Disease Screening System - Product Status
  • Table 74: Intelligent OCT Retinal Disease Screening System - Product Description

List of Figures

  • Figure 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
  • Figure 2: Optical Coherence Tomography (OCT) - Pipeline Products by Territory
  • Figure 3: Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
  • Figure 4: Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
  • Figure 5: Optical Coherence Tomography (OCT) - Ongoing Clinical Trials
目次
Product Code: GDME0853EPD

GlobalData's Medical Devices sector report, "Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2019" provides an overview of Optical Coherence Tomography (OCT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Optical Coherence Tomography (OCT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Optical Coherence Tomography (OCT) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 4
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Optical Coherence Tomography (OCT) Overview 7

3 Products under Development 8

  • 3.1 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development 8
  • 3.2 Optical Coherence Tomography (OCT) - Pipeline Products by Territory 9
  • 3.3 Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path 10
  • 3.4 Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date 11
  • 3.5 Optical Coherence Tomography (OCT) - Ongoing Clinical Trials 12

4 Optical Coherence Tomography (OCT) - Pipeline Products under Development by Companies 13

  • 4.1 Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development 13
  • 4.2 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development 14

5 Optical Coherence Tomography (OCT) Companies and Product Overview 15

  • 5.1 Canon USA Inc Company Overview 15
    • 5.1.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 Carl Zeiss Meditec AG Company Overview 16
    • 5.2.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 Compact Imaging Inc. Company Overview 17
    • 5.3.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 Conavi Medical Inc. Company Overview 18
    • 5.4.1 Conavi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.5 Costruzioni Strumenti Oftalmici Cso Srl Company Overview 19
    • 5.5.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.6 Duke University Company Overview 20
    • 5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.7 George Washington University Company Overview 23
    • 5.7.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.8 Haag-Streit AG Company Overview 24
    • 5.8.1 Haag-Streit AG Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.9 Heidelberg Engineering GmbH Company Overview 25
    • 5.9.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.10 Leica Microsystems GmbH Company Overview 27
    • 5.10.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.11 Moorfields Eye Hospital NHS Foundation Trust Company Overview 29
    • 5.11.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.12 Nippon Telegraph and Telephone Corp Company Overview 32
    • 5.12.1 Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.13 Notal Vision Inc Company Overview 33
    • 5.13.1 Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.14 OptoQuest Company Overview 37
    • 5.14.1 OptoQuest Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.15 Optos Plc Company Overview 38
    • 5.15.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.16 Optovue Inc Company Overview 41
    • 5.16.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.17 Rowiak GmbH Company Overview 42
    • 5.17.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.18 Sinoora Inc. Company Overview 43
    • 5.18.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.19 University of California Berkeley Company Overview 44
    • 5.19.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.20 University of Illinois at Chicago Company Overview 45
    • 5.20.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.21 University of Liverpool Company Overview 46
    • 5.21.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.22 University of Pittsburgh Company Overview 47
    • 5.22.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.23 University of Rochester Company Overview 48
    • 5.23.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.24 University of Texas at Austin Company Overview 49
    • 5.24.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 49

6 Optical Coherence Tomography (OCT)- Recent Developments 50

  • 6.1 Oct 12, 2019: ZEISS showcases next-level eye care digitalization at AAO 2019 50
  • 6.2 Oct 09, 2019: Canon U.S.A. to showcase eyecare solutions At American Academy of Ophthalmology 2019 Meeting 52
  • 6.3 Oct 09, 2019: Topcon to attend American Academy of Ophthalmology 2019 Meeting 53
  • 6.4 Sep 17, 2019: Canon Xephilio OCT-A1 Optical Coherence Tomography Device receives FDA 510(k) clearance 53
  • 6.5 Sep 16, 2019: Ping an energizes Smart Healthcare with technology, Healthcare Ecosystem to be a future highlight 54

7 Appendix 75

  • 7.1 Methodology 75
  • 7.2 About GlobalData 78
  • 7.3 Contact Us 78
  • 7.4 Disclaimer 78
Back to Top